Drugs

News and Updates about the regulations in Drugs and Pharma

Alloy Therapeutics Partners with Takeda to Advance Cell Therapy Framework

Alloy Therapeutics Inc., a biotechnology company committed to making advanced drug discovery technologies more accessible, has entered into a strategic partnership and license agreement with Takeda Pharmaceutical Company Limited. This collaboration aims to enhance Takeda’s advanced iPSC-derived CAR-T cell platform […]

Alloy Therapeutics Partners with Takeda to Advance Cell Therapy Framework Read More »

Urban Genomic Research Links Genetic Profiling to Increased Survival Rates

**Headline:** Urban Genomic Research Links Genetic Profiling to Increased Survival Rates **Content:** Over a span of seven years (2015-2021), Metropolis Healthcare embarked on a pivotal research endeavor to investigate the clinicopathological characteristics and molecular transformations in patients with lung cancer.

Urban Genomic Research Links Genetic Profiling to Increased Survival Rates Read More »

Sahyadri Hospitals Achieves Breakthrough in Safely Removing Rare Brain Tumour from 57-Year-Old using Cutting-Edge Neurosurgical Techniques

A 57-year-old woman, experiencing intense headaches and mobility issues, has made a substantial recovery after a sophisticated neurosurgical procedure at Sahyadri Super Speciality Hospital, Hadapsar. Having previously consulted several hospitals in the vicinity, she was eventually identified with multiple meningiomas

Sahyadri Hospitals Achieves Breakthrough in Safely Removing Rare Brain Tumour from 57-Year-Old using Cutting-Edge Neurosurgical Techniques Read More »

LoEstro Advisors and Medium Healthcare Report Foresees Indian Healthcare Challenges

A recent study by LoEstro Advisors in cooperation with leading healthcare consultant Medium Healthcare, titled “Hospitals for Bharat,” has highlighted significant challenges alongside potential opportunities within India’s healthcare delivery. The report sheds light on the troubling situation: while small and

LoEstro Advisors and Medium Healthcare Report Foresees Indian Healthcare Challenges Read More »

European Medicines Agency Awards PRIME Designation to NZ-5948 for Treating Certain Cancers

Nurix Therapeutics, a clinical-stage company known for developing drugs that adjust protein levels to target cancer and inflammatory diseases, has announced a significant milestone. The European Medicines Agency (EMA) has designated its drug, NX-5948, for PRIME (PRIority MEdicines) status. This

European Medicines Agency Awards PRIME Designation to NZ-5948 for Treating Certain Cancers Read More »

Kura Oncology and Kyowa Kirin Form Worldwide Partnership for Ziftomenib in Acute Leukemias

**Kura Oncology, Inc., a biopharmaceutical company specializing in clinical-stage drug development, and Kyowa Kirin Co., Ltd., an international specialty pharmaceutical firm, have announced a global partnership.** The agreement focuses on developing and marketing ziftomenib, Kura’s selective oral menin inhibitor, currently

Kura Oncology and Kyowa Kirin Form Worldwide Partnership for Ziftomenib in Acute Leukemias Read More »